基于细菌酸盐的双功能mRNA纳米配方,用于有效的结肠癌免疫疗法
Xiaohua Chen1, Jieping Wu1, Bailing Zhou1
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
ACS applied materials & interfaces
|October 14, 2024
概括
这项研究引入了一种新的双功能mRNA输送系统,使用Lactobacillus reuteri lysate来增强癌症免疫疗法. 该系统在提供IL-23AmRNA方面表现出高效率,并在临床前模型中显著抑制瘤生长.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 基于mRNA的非病毒基因疗法对癌症治疗有希望,但在治疗效率和治疗能力方面面临挑战.
- 免疫原疗法,利用免疫系统对抗癌症,是一个不断发展的策略.
- 肠道细菌Lactobacillus reuteri具有免疫调节特性,有利于减少炎症.
研究的目的:
- 开发一种双功能mRNA输送系统,用于增强癌症免疫治疗.
- 为了研究Lactobacillus reuteri lysate作为mRNA传递系统的组成部分的潜力.
- 在临床前癌症模型中评估开发系统的有效性.
主要方法:
- 准备一个双功能mRNA传递系统,DMP-Lac,代码传递Lactobacillus reuteri lysate和IL-23A mRNA.
- 在体内评估mRNA传递效率和免疫系统激活.
- 在CT26腹部和肺转移模型中评估治疗效果.
- 利用蛋白质芯片技术来阐明它的作用机制.
主要成果:
- DMP-Lac/IL-23A系统实现了75.56%±0.85%的高mRNA传递效率.
- 该系统有效地促进了体内免疫系统的成熟和激活.
- 在转移模型中观察到显著的治疗效果,DMP-Lac/IL-23A组的瘤抑制率为97.92%.
- 乳杆菌reuteri lysate作为一个免疫辅助剂,调节免疫细胞,而IL-23mRNA影响下游因素.
结论:
- 开发的双功能mRNA配方,DMP-Lac/IL-23A,作为一种瘤特定的纳米药物.
- 该系统显示出强大的抗癌免疫治疗效果.
- 它通过将向mRNA输送与免疫刺激相结合,为结肠癌免疫基因疗法提供了一种先进的策略.
相关概念视频
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488


